🧠👀 New case report: VR-based oculography objectively measured oculomotor impairments & treatment response in a patient with MS & INO. 🔗 Read in full from the team at @ruhrunibochum: https://t.co/TGw6llaLcf #MultipleSclerosis #Oculomics #Oculometrics #NeuroOphthalmology

@md_machine secures @TopconHealth as lead investor to advance neurodiagnostics 🧠👀 #oculometrics #neurodiagnostics #medtech https://t.co/UcS2xee66k

Meet us at @ACTRIMS 2025 this week in Florida to discover the latest #oculometric research in people living with #MS

Thanks to the energetic @UKNOSoc for another wonderful #UKNOS annual meeting, supported for the third year by @md_machine! Insightful presentations and a thoughtful outlook on the promising future of #digitaldiagnostics, #precisionmedicine, and #collaboration by @DrMollan

𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐌𝐞𝐚𝐬𝐮𝐫𝐞𝐦𝐞𝐧𝐭 𝐨𝐟 𝐒𝐭𝐫𝐚𝐛𝐢𝐬𝐦𝐮𝐬 𝐀𝐧𝐠𝐥𝐞 𝐔𝐬𝐢𝐧𝐠 𝐚 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐕𝐢𝐫𝐭𝐮𝐚𝐥 𝐑𝐞𝐚𝐥𝐢𝐭𝐲 𝐇𝐞𝐚𝐝𝐬𝐞𝐭 Objective, fast, accurate #orthoptic assessments are crucial for ophthalmic efficiency 👀 🌐 https://t.co/O3VReeSwch

Axel Petzold and Mathias Abegg at the inaugural machineMD neos™ symposium - discussing the dysconjugate tango dance of the eyes, a.k.a. #INO 🕺💃

machineMD’s Phil Norris talk about the potential of the neos in #neuroophthalmology. https://t.co/vBQovRfBWs #gaming #virtualreality

machineMD’s neos™ Receives EU-MDR Class IIa Certification, Marking a Breakthrough in Neuro-Ophthalmic Diagnostics The company’s Quality Management System has been certified as compliant with ISO 13485:2016 🌐 Full Press Release: https://t.co/wsPupBoob1 @TUVSUD #CEMark #MDR

Greetings from @ECTRIMS 2024 🧠👀 Today’s highlight is Dr. Anke Salmen’s poster, 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐨𝐜𝐮𝐥𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐮𝐬𝐢𝐧𝐠 𝐚 𝐕𝐑-𝐡𝐞𝐚𝐝𝐬𝐞𝐭 𝐢𝐧 𝐦𝐨𝐝𝐞𝐫𝐚𝐭𝐞𝐥𝐲 𝐭𝐨 𝐬𝐞𝐯𝐞𝐫𝐞𝐥𝐲 𝐝𝐢𝐬𝐚𝐛𝐥𝐞𝐝 𝐌𝐒 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬. 📍P784 #nystagmus #saccades #INO

Discover how @md_machine enables fast, objective, quantified assessments of the afferent and efferent visual system at the #ESCRSiNovation Day 2024! 👀🧠 𝐒𝐞𝐬𝐬𝐢𝐨𝐧 #4 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐖𝐨𝐫𝐤𝐟𝐥𝐨𝐰: 𝐅𝐫𝐨𝐦 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐑𝐨𝐨𝐦

The finalists - Lens2Recycle, @md_machine, @ophthalytics, @Revitalvision1 and @VisionSciLabs - will present to a panel of industry leaders for a chance to win $10,000 for first, $5,000 for second, and $5,000 for an audience choice award. Register here:

🏆 New challenge cohort 🏆 In partnership with @VSPVisionCare , we’re pleased to announce the cohort for the inaugural #VSPVisionInnovationChallenge. Learn more about the finalists and the final showcase taking place on 8/15 ➡️ https://t.co/TueakTbBNt

👣 👀 This week the @Unispital_USZ hosted project partners from the @UniofExeter, @getgaitQ and @md_machine as they embark on an 18-month research project, funded from a grant awarded by @Innosuisse and @innovateuk, to record digital biomarkers from people with #Parkinson’s.

Did you catch Medical Director and co-founder, Dr. Mathias Abegg at @EunoSsociety this week? 🌐Read the study he presented on #RAPD detection https://t.co/cIcD65G6rA

Congratulations to Prof. Konrad Weber, Medical Advisory Board member of #machineMD, appointed President of @EunoSsociety #NeuroOphthalmology

Check out Dr. Aishwarya Sriram’s poster presentation @EunoSsociety

Congratulations to the team at @ruhrunibochum @RUBMedizin presenting their study at @EunoSsociety of #MyastheniaGravis patients using #VR-based videooculography developed by @md_machine

Neuro-ophthalmologist Aishwarya Sriram joins the team as Medical Liaison.     Dr. Sriram completed her fellowship in Neuro-Ophthalmology at @MassEyeAndEar, followed by a fellowship in Global Ophthalmology at the @MoranEyeCenter, including Mexico, Nepal, Ghana, and Tanzania.

@uhbtrust 👁️‍🗨️ 𝐁𝐞𝐥𝐟𝐚𝐬𝐭 𝐛𝐞𝐥𝐭𝐞𝐫𝐬 Five case reports which may present to the general ophthalmologist with the aim of highlighting red flag symptoms and clinical signs, and key features in investigation and management. Wednesday, 22nd May, 11am https://t.co/5Udpz7OT9a

@uhbtrust 👁️‍🗨️ 𝐃𝐞𝐦𝐲𝐬𝐭𝐢𝐟𝐲𝐢𝐧𝐠 𝐧𝐞𝐮𝐫𝐨-𝐨𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐨𝐥𝐨𝐠𝐲 Exploring common symptoms/signs that may indicate serious pathologies, including visual field defects, pupillometry, double vision, and headaches 📍Tuesday, 21st May, 9.10am https://t.co/swQGgkxt2S